secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2024-05-21T23:59:59+00:00
Accession:  0001104659-24-063835
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics announces $525M convertible senior notes offering due 2029
----------------------------------------------------------------------

- $525M principal amount of convertible senior notes due 2029, with option for additional $75M.
- Notes accrue interest semi-annually, mature June 1, 2029; settlement in cash up to $1,000 principal, then stock/cash.
- Proceeds to fund capped call transactions to offset dilution, plus working capital and general corporate purposes.
- Offering only to qualified institutional buyers under Rule 144A; notes not registered under Securities Act.
- Option counterparties may enter derivative transactions affecting HAE stock price around pricing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000110465924063835/0001104659-24-063835-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000110465924063835/tm2415037d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-063835

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer